Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 18, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Venture Capital
InduPro Raises $77 Million, Doses First Patient in Phase 1 Trial of Lead Cancer Therapy
Life Sciences Times
-
August 12, 2026
0
Biotech
Survey Finds U.S. Biotechs Favor Domestic First-in-Human Trials but Cite FDA Hurdles
Life Sciences Times
-
August 12, 2026
0
Biotech
Three Innoviva Antimicrobial Therapies Named Finalists for 2026 Prix Galien USA Award
Life Sciences Times
-
August 12, 2026
0
Biotech
Thermo Fisher Completes $1.075 Billion Sale of Microbiology Business to Astorg
Life Sciences Times
-
August 12, 2026
0
Healthcare
Kulpa Foundation Opens Applications for Health Innovations Scholarship
Life Sciences Times
-
August 12, 2026
0
People on the Move
Life Biosciences Appoints Former Spark Therapeutics CFO Stephen Webster to Board
Life Sciences Times
-
August 12, 2026
0
People on the Move
Erasca Names Charles Fuchs President of Research and Development
Life Sciences Times
-
August 11, 2026
0
Medtech
908 Devices Q2 Revenue Rises 23%, Company Raises 2026 Outlook
Life Sciences Times
-
August 11, 2026
0
Technology
Bruker Expands Atinary Partnership to Advance AI-Powered Self-Driving Laboratories
Life Sciences Times
-
August 11, 2026
0
People on the Move
City Therapeutics Names Keith Regnante CFO, Mary Beth DeLena Chief Legal Officer
Life Sciences Times
-
August 11, 2026
0
1
...
3
4
5
...
890
Page 4 of 890
Most Popular
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
August 18, 2026
Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer
August 18, 2026
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
August 18, 2026
Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs
August 18, 2026
Load more
Recent Comments
Recent Comments